New 13D25
New 13G50
Stated intents1
The week of 2026-06-08, 25 holders filed a new Schedule 13D and 50 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-06-08 | NYLI MacKay Muni Income Opportunities Fund | NYLIM Capital LLC | 100% | SCHEDULE 13D |
| 2026-06-08 | NYLI MacKay Muni Income Opportunities Fund | NYLIM Capital LLC | 100% | SCHEDULE 13D |
| 2026-06-10 | MINERALRITE Corp | Hendricks Lloyd Bernard III | 100% | SCHEDULE 13D |
| 2026-06-08 | NYLI MacKay Muni Income Opportunities Fund | NYLIM Capital LLC | 80.9% | SCHEDULE 13D |
| 2026-06-12 | JAB Acquisition Corp I | JAB Acquisition Sponsor I, LLC | 36.4% | SCHEDULE 13D |
| 2026-06-08 | Tribeca Strategic Acquisition Corp. | Tribeca Strategic Partners Holdco LLC | 25.6% | SCHEDULE 13D |
| 2026-06-11 | Amanat Acquisition Corp | Amanat Sponsor Holdings LLC | 24.7% | SCHEDULE 13D |
| 2026-06-09 | Amplify ETF Trust | Hennion & Walsh Asset Management, Inc. | 24.21% | SCHEDULE 13D |
| 2026-06-10 | InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. | 21.7% | SCHEDULE 13D |
| 2026-06-11 | AmperCap Acquisition Co | AmperSPAC LLC | 19.61% | SCHEDULE 13D |
| 2026-06-12 | Cartesian Growth Corp III | Huang Siyu | 19.1% | SCHEDULE 13D |
| 2026-06-11 | Saker Aviation Services, Inc. | Eriksen Capital Management LLC | 17.5% | SCHEDULE 13D |
| 2026-06-09 | TELA Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | 17.23% | SCHEDULE 13D |
| 2026-06-11 | Designer Brands Inc. | Stone House Capital Management, LLC | 16.3% | SCHEDULE 13D |
| 2026-06-12 | Standard Biotools Inc. | Viking Global Investors LP | 15% | SCHEDULE 13D |
| 2026-06-12 | Liftoff Mobile, Inc. | General Atlantic, L.P. | 15% | SCHEDULE 13D |
| 2026-06-09 | Coincheck Group N.V. | KDDI Corporation | 14.9% | SCHEDULE 13D |
| 2026-06-10 | MINERALRITE Corp | Hendricks Lloyd Bernard III | 14.7% | SCHEDULE 13D |
| 2026-06-10 | MINERALRITE Corp | Hendricks Lloyd Bernard III | 14.5% | SCHEDULE 13D |
| 2026-06-08 | OceanFirst Financial Corp. | Warburg Pincus LLC ("WP LLC") | 9.9% | SCHEDULE 13D |
| 2026-06-11 | Gossamer Bio, Inc. | D. E. Shaw & Co., L.P. | 9.5% | SCHEDULE 13D |
| 2026-06-10 | American Fusion, Inc. | Hawkins Richard C. | 8.59% | SCHEDULE 13D |
| 2026-06-12 | Cartesian Growth Corp III | Mercedes-Benz Corporate Investments LLC | 8.1% | SCHEDULE 13D |
| 2026-06-11 | Galera Therapeutics, Inc. | Parvinder Singh Hyare | 6.65% | SCHEDULE 13D |
| 2026-06-10 | NextDecade Corp | GAP Holdings GP, LLC | 5.9% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-06-12 | WeShop Holdings Ltd | Sidney PTC Ltd | 22.37% | SCHEDULE 13G |
| 2026-06-11 | Patriot Acquisition Corp. | Patriot Acquisition Sponsor LLC | 20% | SCHEDULE 13G |
| 2026-06-08 | WORK Medical Technology Group LTD | Trillium Trading, LLC | 18% | SCHEDULE 13G |
| 2026-06-10 | Global Innovative Platforms Inc. | Jones James Carl | 14.99% | SCHEDULE 13G |
| 2026-06-09 | SPAR Group, Inc. | ReposiTrak, Inc. | 14.8% | SCHEDULE 13G |
| 2026-06-11 | Aditxt, Inc. | Diaz Rodriguez Agustin | 13.8% | SCHEDULE 13G |
| 2026-06-11 | Aditxt, Inc. | Xu Devon Xin | 12.3% | SCHEDULE 13G |
| 2026-06-11 | Canada Goose Holdings Inc. | Wbt Value Limited | 10.01% | SCHEDULE 13G |
| 2026-06-09 | Sintx Technologies Inc | Lytton Laurence W | 9.99% | SCHEDULE 13G |
| 2026-06-10 | Patriot National Bancorp Inc | Alon Abady | 9.99% | SCHEDULE 13G |
| 2026-06-11 | Gossamer Bio, Inc. | 683 Capital Management, LLC | 9.99% | SCHEDULE 13G |
| 2026-06-09 | Gossamer Bio, Inc. | Context Capital Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-06-09 | Sintx Technologies Inc | Stonepine Capital Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-06-10 | American Fusion, Inc. | Pinnacle Consulting Services Inc. | 8.99% | SCHEDULE 13G |
| 2026-06-10 | Aeon Acquisition I Corp. | Harraden Circle Investments, LLC | 8.77% | SCHEDULE 13G |
| 2026-06-10 | Fulcrum Therapeutics, Inc. | Tang Capital Management, LLC | 8.2% | SCHEDULE 13G |
| 2026-06-08 | Esperion Therapeutics, Inc. | Glazer Capital, LLC | 8.15% | SCHEDULE 13G |
| 2026-06-08 | Akari Therapeutics Plc | MMCAP International Inc. SPC | 8% | SCHEDULE 13G |
| 2026-06-11 | Gossamer Bio, Inc. | DeepCurrents Investment Group LLC | 7.7% | SCHEDULE 13G |
| 2026-06-11 | FutureCorp Space Acquisition 1 | Linden Capital L.P. | 7.6% | SCHEDULE 13G |
| 2026-06-08 | Beasley Broadcast Group Inc | Kingdom Capital Advisors LLC | 7.2% | SCHEDULE 13G |
| 2026-06-10 | Quince Therapeutics, Inc. | Integrated Core Strategies (US) LLC | 7.2% | SCHEDULE 13G |
| 2026-06-10 | FONAR Corp | Andrew Berger | 7.1% | SCHEDULE 13G |
| 2026-06-09 | Interprivate Investment Partners V Inc | MMCAP International Inc. SPC | 7% | SCHEDULE 13G |
| 2026-06-08 | FutureCorp Space Acquisition 1 | MMCAP International Inc. SPC | 6.5% | SCHEDULE 13G |
| 2026-06-12 | Aeon Acquisition I Corp. | Space Summit Capital LLC | 6.5% | SCHEDULE 13G |
| 2026-06-09 | Relmada Therapeutics, Inc. | Venrock Healthcare Capital Partners III, L.P. | 6.2% | SCHEDULE 13G |
| 2026-06-10 | AmperCap Acquisition Co | Sculptor Capital LP | 6.11% | SCHEDULE 13G |
| 2026-06-08 | Wolfspeed, Inc. | Css LLC | 5.91% | SCHEDULE 13G |
| 2026-06-11 | Long Table Growth Corp | Sculptor Capital LP | 5.8% | SCHEDULE 13G |
| 2026-06-09 | Geovax Labs, Inc. | Jane Street Group, LLC | 5.6% | SCHEDULE 13G |
| 2026-06-12 | BuzzFeed, Inc. | Inventive Sino Limited | 5.6% | SCHEDULE 13G |
| 2026-06-11 | Aeon Acquisition I Corp. | Feis Equities LLC | 5.59% | SCHEDULE 13G |
| 2026-06-12 | Motorsport Games Inc. | Red Oak Partners, LLC | 5.5% | SCHEDULE 13G |
| 2026-06-12 | FutureCorp Space Acquisition 1 | Harraden Circle Investments, LLC | 5.43% | SCHEDULE 13G |
| 2026-06-11 | Once Upon a Farm, PBC | Millennium Management LLC | 5.4% | SCHEDULE 13G |
| 2026-06-11 | Rubico Inc. | Trillium Trading, LLC | 5.4% | SCHEDULE 13G |
| 2026-06-12 | Optimum Communications, Inc. | Subin Neil S | 5.4% | SCHEDULE 13G |
| 2026-06-11 | Infleqtion, Inc. | S&G Foundation | 5.3% | SCHEDULE 13G |
| 2026-06-11 | Zai Lab Limited | Chen Yu | 5.3% | SCHEDULE 13G |
| 2026-06-08 | Forte Biosciences, Inc. | Millennium Management LLC | 5.2% | SCHEDULE 13G |
| 2026-06-11 | Long Table Growth Corp | Linden Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-06-10 | Tecogen Inc. | Portolan Capital Management, LLC | 5.19% | SCHEDULE 13G |
| 2026-06-11 | Xwell | Richard Abbe | 5.14% | SCHEDULE 13G |
| 2026-06-09 | Design Therapeutics, Inc. | Point72 Asset Management, L.P. | 5.1% | SCHEDULE 13G |
| 2026-06-09 | Lixte Biotechnology Holdings Inc | Strategic EP, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-09 | Bitdeer Technologies Group | Jane Street Group, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-10 | D. Boral ARC Acquisition I Corp. | Merus Global Investments, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-09 | Tower Semiconductor Ltd | Phoenix Financial Ltd. | 5.01% | SCHEDULE 13G |
| 2026-06-11 | Sonida Senior Living, Inc. | Pertento Partners LLP | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-06-10 | Braemar Hotels & Resorts Inc. | Al Shams Investments LTD intent stated | 9.55% | SCHEDULE 13D/A |
Download this data (CSV)78 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.